The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism.
Resistance to Covid drug detected in lab study miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
U.S.-based pharmaceutical giant Merck & Co. on Friday, Oct. 1, said it would seek authorization for the first oral antiviral pill to treat COVID-19, after a clinical trial showed it cut the risk of hospitalization or death in half when given to high-risk people during infection.The drug, known as molnupiravir, was first shown to be efficacious against coronaviruses including the COVID-19 virus, SARS-CoV-2, by investigators in the lab of Mark Denison, MD, at Vanderbilt Universi .
The drug, known as molnupiravir, was first shown to be efficacious against coronaviruses, including the COVID-19 virus, SARS-CoV-2, by investigators at Vanderbilt University Medical Center.